Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1100320150320020102
Yeungnam University Journal of Medicine
2015 Volume.32 No. 2 p.102 ~ p.105
Secondary amyloidosis complication of Crohn disease treated with infliximab
Song Min-Joo

Kim Hyo-Sang
Park So-Young
Cheon Jae-Kyung
Park So-Jung
Yang Ji-Young
Park Su-Kil
Abstract
Secondary systemic (AA) amyloidosis is a severe complication of progressed Crohn disease (CD) characterized by the deposition of amyloid A in body organs and tissues. Various therapeutic approaches have been recommended, however there is still no effective treatment. Recently, several case reports have demonstrated the effects of anti-tumor necrosis factor-¥á therapy in patients with AA amyloidosis associated with CD. We report on a 35-year-old female patient with CD complicated by AA amyloidosis in the gastrointestinal tract and renal involvement, who was treated with infliximab. The infliximab therapy improved the gastrointestinal symptoms and decreased the serum creatinine.
KEYWORD
Crohn disease, Amyloidosis, Infliximab
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed